Stock listing
OTC:CLDGF CLEO Diagnostics Ltd Stock
US listing (OTC) of CLEO Diagnostics Ltd · home listing ASX:COV
Follow CLEO Diagnostics Ltd into a list and get an email when it puts out news.
Home listing price · ASX:COV
$0.295 AUD 0.000 (0.0%)
Delayed at least 15 minutes · 9:59 AM GMT+11, Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, ASX:COV
- Day range so far
- $0.295 – $0.295 AUDDelayed at least 15 minutes · 9:59 AM GMT+11, Nov 2, 2026
- Volume
- 96 sharesDelayed at least 15 minutes · 9:59 AM GMT+11, Nov 2, 2026
- Market cap
- $42.00M AUDDelayed at least 15 minutes · 9:59 AM GMT+11, Nov 2, 2026 · price × 142.4M shares outstanding
- 52-week range
- $0.270 – $0.900 AUDLowest and highest trades, Nov 3, 2025 – Nov 1, 2026
- Traded on an average day
- $35,881 AUDMedian day 83,264 shares · 1 day with no trades · last 3 months, Aug 3, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:COV · Home | $0.295 AUD | 0.000 (0.0%) | 96 | $0.295 | $0.295 | $0.295 | $0.295 | Delayed 15+ min · 9:59 AM GMT+11, Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Oct 30, 2026 · ASX:COV · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.295 | -0.005 | -1.7% | $0.300 | $0.300 | $0.295 | 140,150 | |
| $0.300 | +0.005 | +1.7% | $0.295 | $0.300 | $0.295 | 11,569 | |
| $0.295 | 0.000 | 0.0% | $0.295 | $0.300 | $0.295 | 58,780 | |
| $0.295 | -0.010 | -3.3% | $0.305 | $0.305 | $0.295 | 47,536 | |
| $0.305 | -0.015 | -4.7% | $0.305 | $0.305 | $0.293 | 85,936 | |
| $0.320 | +0.015 | +4.9% | $0.312 | $0.320 | $0.312 | 2,123 | |
| $0.305 | -0.010 | -3.2% | $0.305 | $0.315 | $0.300 | 68,808 | |
| $0.315 | +0.010 | +3.3% | $0.345 | $0.355 | $0.305 | 237,701 | |
| $0.305 | 0.000 | 0.0% | $0.305 | $0.305 | $0.305 | 6,938 | |
| $0.305 | -0.005 | -1.6% | $0.320 | $0.320 | $0.300 | 106,387 | |
| $0.310 | -0.010 | -3.1% | $0.310 | $0.310 | $0.310 | 2,000 | |
| $0.320 | -0.010 | -3.0% | $0.330 | $0.330 | $0.295 | 171,047 | |
| $0.330 | -0.015 | -4.3% | $0.340 | $0.340 | $0.315 | 78,853 | |
| $0.345 | -0.005 | -1.4% | $0.350 | $0.360 | $0.330 | 204,569 | |
| $0.350 | +0.035 | +11.1% | $0.320 | $0.350 | $0.310 | 128,274 | |
| $0.315 | +0.005 | +1.6% | $0.315 | $0.320 | $0.315 | 58,821 | |
| $0.310 | -0.010 | -3.1% | $0.315 | $0.315 | $0.310 | 25,303 | |
| $0.320 | -0.030 | -8.6% | $0.350 | $0.350 | $0.320 | 6,611 | |
| $0.350 | 0.000 | 0.0% | $0.340 | $0.350 | $0.340 | 1,500 | |
| $0.350 | +0.005 | +1.4% | $0.335 | $0.350 | $0.335 | 25,547 | |
| $0.345 | +0.025 | +7.8% | $0.320 | $0.345 | $0.315 | 202,365 | |
| $0.320 | +0.035 | +12.3% | $0.305 | $0.320 | $0.295 | 123,565 | |
| $0.285 | +0.005 | +1.8% | $0.285 | $0.300 | $0.285 | 77,261 | |
| $0.280 | -0.010 | -3.4% | $0.290 | $0.290 | $0.280 | 48,985 | |
| $0.290 | -0.005 | -1.7% | $0.295 | $0.295 | $0.280 | 91,791 | |
| $0.295 | 0.000 | 0.0% | $0.295 | $0.295 | $0.270 | 570,452 | |
| $0.295 | -0.010 | -3.3% | $0.305 | $0.305 | $0.290 | 809,172 | |
| $0.305 | -0.025 | -7.6% | $0.320 | $0.320 | $0.295 | 133,221 | |
| $0.330 | +0.030 | +10.0% | $0.310 | $0.335 | $0.310 | 224,917 | |
| $0.300 | -0.010 | -3.2% | $0.310 | $0.315 | $0.295 | 189,247 | |
| $0.310 | -0.015 | -4.6% | $0.320 | $0.320 | $0.310 | 50,203 | |
| $0.325 | +0.010 | +3.2% | $0.315 | $0.325 | $0.293 | 197,552 | |
| $0.315 | +0.005 | +1.6% | $0.320 | $0.325 | $0.315 | 17,760 | |
| $0.310 | -0.025 | -7.5% | $0.340 | $0.345 | $0.310 | 130,740 | |
| $0.335 | +0.020 | +6.3% | $0.340 | $0.340 | $0.335 | 27,580 | |
| $0.315 | -0.025 | -7.4% | $0.325 | $0.325 | $0.315 | 172,265 | |
| $0.340 | 0.000 | 0.0% | $0.330 | $0.355 | $0.325 | 154,485 | |
| $0.340 | -0.010 | -2.9% | $0.340 | $0.340 | $0.330 | 94,543 | |
| $0.350 | -0.005 | -1.4% | $0.355 | $0.355 | $0.350 | 54,100 | |
| $0.355 | -0.030 | -7.8% | $0.370 | $0.370 | $0.355 | 33,835 | |
| $0.385 | -0.015 | -3.8% | $0.410 | $0.420 | $0.360 | 126,308 | |
| $0.400 | +0.050 | +14.3% | $0.395 | $0.400 | $0.385 | 50,247 | |
| $0.350 | 0.000 | 0.0% | $0.350 | $0.350 | $0.350 | 0 | |
| $0.350 | +0.005 | +1.4% | $0.345 | $0.360 | $0.340 | 62,943 | |
| $0.345 | 0.000 | 0.0% | $0.345 | $0.345 | $0.345 | 27,934 | |
| $0.345 | +0.005 | +1.5% | $0.340 | $0.345 | $0.325 | 204,681 | |
| $0.340 | -0.020 | -5.6% | $0.335 | $0.350 | $0.335 | 12,277 | |
| $0.360 | +0.005 | +1.4% | $0.345 | $0.360 | $0.340 | 57,676 | |
| $0.355 | +0.015 | +4.4% | $0.345 | $0.355 | $0.335 | 57,510 | |
| $0.340 | +0.023 | +7.1% | $0.325 | $0.340 | $0.325 | 132,816 | |
| $0.318 | -0.013 | -3.8% | $0.320 | $0.323 | $0.315 | 39,565 | |
| $0.330 | 0.000 | 0.0% | $0.340 | $0.340 | $0.330 | 135,142 | |
| $0.330 | 0.000 | 0.0% | $0.330 | $0.340 | $0.325 | 193,176 | |
| $0.330 | -0.010 | -2.9% | $0.330 | $0.335 | $0.330 | 131,996 | |
| $0.340 | -0.005 | -1.4% | $0.345 | $0.345 | $0.330 | 75,472 | |
| $0.345 | -0.015 | -4.2% | $0.360 | $0.360 | $0.340 | 83,264 | |
| $0.360 | +0.025 | +7.5% | $0.340 | $0.360 | $0.340 | 64,375 | |
| $0.335 | -0.005 | -1.5% | $0.330 | $0.335 | $0.330 | 6,798 | |
| $0.340 | 0.000 | 0.0% | $0.340 | $0.345 | $0.320 | 140,325 | |
| $0.340 | +0.010 | +3.0% | $0.330 | $0.345 | $0.330 | 114,017 | |
| $0.330 | 0.000 | 0.0% | $0.328 | $0.330 | $0.325 | 16,872 | |
| $0.330 | -0.005 | -1.5% | $0.343 | $0.345 | $0.325 | 103,157 | |
| $0.335 | -0.020 | -5.6% | $0.345 | $0.345 | $0.335 | 118,794 | |
| $0.355 | -0.005 | -1.4% | $0.380 | $0.380 | $0.340 | 140,393 | |
| $0.360 | +0.015 | +4.3% | $0.350 | $0.395 | $0.350 | 241,888 |
- Ticker
- OTC:CLDGF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 20, 2026
CLEO Screening Test Meets Rigorous Performance Targets
Latest news
CLEO Screening Test Meets Rigorous Performance Targets
Oct 20, 2026
Closed $0.315 (+3.3%) on Oct 21, 2026
CLEO Commences Analytical Validation Ahead of FDA Submission
Oct 12, 2026
Closed $0.345 (-1.4%) on Oct 13, 2026
Cleo Files Patents for its Ovarian Cancer Screening Test
Sep 29, 2026
Closed $0.285 (+1.8%) on Sep 30, 2026
CLEO Commences Ovarian Cancer Screening Test Development
Sep 23, 2026
Closed $0.295 (-3.3%) on Sep 24, 2026
CLIA Certified Lab selected - Pivotal US Clinical Validation
Sep 9, 2026
Closed $0.34 (0.0%) on Sep 10, 2026
CLEO Receives First Batch of Commercial Test Kits
Sep 2, 2026
Closed $0.40 (+14.3%) on Sep 3, 2026
Appendix 4E and 2026 Annual Report
Aug 20, 2026
Closed $0.318 (-3.8%) on Aug 21, 2026
CLEO Enters Analytical Validation Phase
Jul 12, 2026
Closed $0.485 (-4.9%) on Jul 13, 2026
CLEO Establishes U.S. Reimbursement Pathway
May 19, 2026
Closed $0.61 (-3.9%) on May 20, 2026
Decks
Investor Presentation (June 2025)
Investor deck · 22 slides · Jun 12, 2025
Investor Presentation (February 2024)
Investor deck · 21 slides · Feb 20, 2024
CLEO Diagnostics Ltd on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 23 in the last 12 months · 49 in all · newest Oct 30, 2026 · oldest 2023
- Decks
- 2 decks · latest Jun 12, 2025
Where CLEO Diagnostics Ltd is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:COV · Home listing | ASX | Australia | AUD |
| OTC:CLDGF · This page | OTC | United States | USD |
Log in to ask 6ix AI your own questions about CLEO Diagnostics Ltd.